Title |
Interventions for cutaneous Bowen's disease
|
---|---|
Published in |
Cochrane database of systematic reviews, June 2013
|
DOI | 10.1002/14651858.cd007281.pub2 |
Pubmed ID | |
Authors |
Fiona J Bath‐Hextall, Rubeta N Matin, David Wilkinson, Jo Leonardi‐Bee |
Abstract |
Bowen's disease is the clinical term for in situ squamous cell carcinoma of the skin. Cutaneous lesions present as largely asymptomatic, well-defined, scaly erythematous patches on sun-exposed skin. In general, people with Bowen's disease have an excellent prognosis because the disease is typically slow-growing and responds favourably to treatment. Lesions are persistent and can be progressive, with a small potential (estimated to be 3%) to develop into invasive squamous cell carcinoma. The relative effectiveness of the available treatments is not known for Bowen's disease, and this review attempts to address which is the most effective intervention, with the least side-effects, for cutaneous Bowen's disease. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | <1% |
Unknown | 264 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 37 | 14% |
Student > Bachelor | 34 | 13% |
Researcher | 27 | 10% |
Student > Ph. D. Student | 22 | 8% |
Other | 20 | 8% |
Other | 52 | 20% |
Unknown | 74 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 105 | 39% |
Nursing and Health Professions | 27 | 10% |
Psychology | 14 | 5% |
Unspecified | 8 | 3% |
Biochemistry, Genetics and Molecular Biology | 7 | 3% |
Other | 26 | 10% |
Unknown | 79 | 30% |